Cardiovascular disease is a known determinant of morbidity and mortality in patients undergoing kidney transplantation, which is the commonly chosen treatment for patients with end-stage kidney disease. Researchers for this study sought to examine the rate of major cardiovascular adverse events (MACEs), in the context of an aging transplant population on waitlists, higher diabetic populations and increasing dialysis pre-transplantation, specifically for the perioperative kidney transplantation period.